SG11202111940XA - Method of predicting cancer prognosis and composition for same - Google Patents
Method of predicting cancer prognosis and composition for sameInfo
- Publication number
- SG11202111940XA SG11202111940XA SG11202111940XA SG11202111940XA SG11202111940XA SG 11202111940X A SG11202111940X A SG 11202111940XA SG 11202111940X A SG11202111940X A SG 11202111940XA SG 11202111940X A SG11202111940X A SG 11202111940XA SG 11202111940X A SG11202111940X A SG 11202111940XA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- same
- cancer prognosis
- predicting cancer
- predicting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/165—Mathematical modelling, e.g. logarithm, ratio
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190052364 | 2019-05-03 | ||
| PCT/KR2020/005624 WO2020226333A1 (fr) | 2019-05-03 | 2020-04-28 | Méthode de prédiction et de pronostic du cancer et composition à cet effet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202111940XA true SG11202111940XA (en) | 2021-12-30 |
Family
ID=73051303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111940XA SG11202111940XA (en) | 2019-05-03 | 2020-04-28 | Method of predicting cancer prognosis and composition for same |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220267855A1 (fr) |
| EP (1) | EP3964590A4 (fr) |
| JP (1) | JP2022530570A (fr) |
| KR (5) | KR102449386B1 (fr) |
| CN (1) | CN113785076B (fr) |
| SG (1) | SG11202111940XA (fr) |
| WO (1) | WO2020226333A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102293110B1 (ko) * | 2020-12-07 | 2021-08-25 | 주식회사 온코크로스 | Ai를 이용한 유방암 예후 예측 방법 |
| CN112852966A (zh) * | 2021-03-23 | 2021-05-28 | 复旦大学附属肿瘤医院 | 基于二代测序技术的胰腺癌检测panel、试剂盒及其应用 |
| KR20230014990A (ko) | 2021-07-22 | 2023-01-31 | 주식회사 라파메디랩 | 대장암 진단 또는 예후 예측용 바이오마커 |
| GB2613386A (en) * | 2021-12-02 | 2023-06-07 | Apis Assay Tech Limited | Diagnostic test |
| CN114047337A (zh) * | 2021-12-27 | 2022-02-15 | 复旦大学附属中山医院 | 一种与肝细胞癌患者预后相关的分子标志物、免疫组化试剂盒及其应用 |
| CN114438218B (zh) * | 2022-04-01 | 2022-08-09 | 普瑞基准科技（北京）有限公司 | 一种检测多种肿瘤的基因Panel、试剂盒及应用 |
| CN114592065B (zh) * | 2022-04-21 | 2023-12-12 | 青岛市市立医院 | 一组预测肝癌预后联合标志物及其应用 |
| KR102560831B1 (ko) * | 2022-05-31 | 2023-08-02 | 서울대학교병원 | 위암 발병 가능성 예측을 위한 바이오마커 및 이의 용도 |
| CN114908172B (zh) * | 2022-06-02 | 2024-02-27 | 河南省人民医院 | Apobec3b在前列腺癌诊断、预后预测及治疗中的应用 |
| KR20240033900A (ko) | 2022-09-06 | 2024-03-13 | 충남대학교산학협력단 | Shmt2를 타겟으로 하는 갑상선암 예방 또는 치료용 조성물 |
| CN117607442B (zh) * | 2024-01-23 | 2024-04-16 | 杭州华得森生物技术有限公司 | 一种预测乳腺癌免疫治疗效果的标志物、试剂盒与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1836629T3 (pl) | 2004-11-05 | 2020-06-15 | Genomic Health, Inc. | Przewidywanie odpowiedzi na chemioterapię z zastosowaniem markerów ekspresji genu |
| EP2544006A1 (fr) * | 2007-06-04 | 2013-01-09 | Diagnoplex | Combinaisons de bio-marqueurs du cancer colorectal |
| ES2595410T3 (es) * | 2009-01-07 | 2016-12-29 | Myriad Genetics, Inc. | Biomarcadores de cáncer |
| AU2015268617A1 (en) * | 2010-03-31 | 2016-01-07 | Sividon Diagnostics Gmbh | Method for breast cancer recurrence prediction under endocrine treatment |
| WO2013109690A1 (fr) * | 2012-01-17 | 2013-07-25 | Myriad Genetics, Inc. | Signatures pour le pronostic du cancer du sein |
| US9624549B2 (en) * | 2012-01-27 | 2017-04-18 | Cytognomix Inc. | Stable gene targets in breast cancer and use thereof for optimizing therapy |
| US20150218648A1 (en) * | 2012-08-01 | 2015-08-06 | Pacylex Pharmaceuticals Inc. | Methods and compositions for diagnosis and prognosis in breast cancer |
| WO2014066796A2 (fr) * | 2012-10-25 | 2014-05-01 | Myriad Genetics, Inc. | Signatures de pronostic du cancer du sein |
| KR101725985B1 (ko) * | 2013-01-28 | 2017-04-13 | 주식회사 젠큐릭스 | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 |
| US11946934B2 (en) * | 2014-09-03 | 2024-04-02 | Wellmarker Bio Co., Ltd. | Biomarker for predicting the sensitivity to a protein kinase inhibitor and a use thereof |
| EP3387168B1 (fr) | 2015-12-07 | 2021-05-12 | Ontario Institute for Cancer Research (OICR) | Signature génique du risque résiduel après traitement endocrinien dans un cancer du sein précoce |
| EP3464619A1 (fr) * | 2016-05-25 | 2019-04-10 | CureVac AG | Nouveaux biomarqueurs |
| KR20180052985A (ko) * | 2016-11-11 | 2018-05-21 | 서울대학교병원 | 유방암 예후 예측 유전자의 차세대염기서열분석을 이용한 유방암의 예후 예측 도구 |
| KR102050949B1 (ko) * | 2017-02-15 | 2019-12-03 | 서울대학교산학협력단 | Nr1d1을 이용한 삼중-음성 유방암 환자의 항암제 치료 반응성 및 예후 예측 방법 |
| WO2018169145A1 (fr) * | 2017-03-14 | 2018-09-20 | (주) 노보믹스 | Système de prédiction de pronostic post-chirurgie ou de compatibilité vis-à-vis de médicaments anticancéreux de patients atteints d'un cancer gastrique avancé |
| KR102071491B1 (ko) * | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
| CN109136370A (zh) * | 2018-05-31 | 2019-01-04 | 广州表观生物科技有限公司 | 一种肺癌的预后标记物及其应用 |
-
2020
- 2020-04-28 WO PCT/KR2020/005624 patent/WO2020226333A1/fr unknown
- 2020-04-28 JP JP2021565712A patent/JP2022530570A/ja active Pending
- 2020-04-28 SG SG11202111940XA patent/SG11202111940XA/en unknown
- 2020-04-28 CN CN202080033495.1A patent/CN113785076B/zh active Active
- 2020-04-28 US US17/608,422 patent/US20220267855A1/en active Pending
- 2020-04-28 KR KR1020200051363A patent/KR102449386B1/ko active IP Right Grant
- 2020-04-28 EP EP20802982.7A patent/EP3964590A4/fr active Pending
-
2022
- 2022-09-27 KR KR1020220122073A patent/KR102565758B1/ko active IP Right Grant
- 2022-09-27 KR KR1020220122082A patent/KR102640719B1/ko active IP Right Grant
- 2022-12-20 KR KR1020220179252A patent/KR102648633B1/ko active IP Right Grant
- 2022-12-20 KR KR1020220179268A patent/KR102648636B1/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220137578A (ko) | 2022-10-12 |
| KR20220137577A (ko) | 2022-10-12 |
| KR102449386B1 (ko) | 2022-10-05 |
| KR20230004398A (ko) | 2023-01-06 |
| KR102648633B1 (ko) | 2024-03-19 |
| JP2022530570A (ja) | 2022-06-29 |
| CN113785076B (zh) | 2024-06-11 |
| KR20230004397A (ko) | 2023-01-06 |
| WO2020226333A1 (fr) | 2020-11-12 |
| EP3964590A4 (fr) | 2023-06-21 |
| KR102565758B1 (ko) | 2023-08-14 |
| KR102648636B1 (ko) | 2024-03-19 |
| US20220267855A1 (en) | 2022-08-25 |
| CN113785076A (zh) | 2021-12-10 |
| KR20200127878A (ko) | 2020-11-11 |
| KR102640719B1 (ko) | 2024-02-27 |
| EP3964590A1 (fr) | 2022-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202111940XA (en) | Method of predicting cancer prognosis and composition for same | |
| IL288754A (en) | Preparations and methods for cancer immunotherapy | |
| IL287248A (en) | Methods and preparations for editing RN" A | |
| GB2587970B (en) | Compositions and methods for gene editing | |
| IL268524A (en) | Immunological biomarker for predicting clinical outcome of cancer immunotherapy | |
| EP3761849A4 (fr) | Méthode pour détecter et/ou prédire des événements épileptiques | |
| EP3792362A4 (fr) | Méthode et kit pour identifier l'état d'un cancer colorectal | |
| EP3814525A4 (fr) | Méthodes de traitement et biomarqueurs pour des inhibiteurs de mdm2 | |
| EP3648200A4 (fr) | Procédé pour prédire l'aptitude au traitement d'une suspension d'électrode et sélectionner un liant d'électrode | |
| EP3891236B8 (fr) | Composition et procédé de polissage chimico-mecanique de metal | |
| IL284827A (en) | A biomarker panel for the diagnosis and prognosis of cancer | |
| EP3674706A4 (fr) | Procédé d'évaluation d'un effet anticancéreux et procédé de prédiction de l'efficacité d'une immunothérapie anticancéreuse | |
| EP3746087A4 (fr) | Méthodes de prédiction précoce et de prévention de la prééclampsie faisant appel à des biomarqueurs associés à des microparticules circulantes | |
| EP3669370A4 (fr) | Procédé de détermination d'arnm cellulaire | |
| EP3950954A4 (fr) | Méthode pour déterminer le pronostic d'un cancer de l'endomètre | |
| EP4065731A4 (fr) | Méthodes et compositions destinées à des analyses du cancer | |
| SG11202109835WA (en) | Methods for predicting prostate cancer and uses thereof | |
| EP3833779A4 (fr) | Motif d'expression combiné d'organisateurs de la chromatine de la famille des satb en tant qu'outil de biomarqueur amélioré pour le pronostic du cancer | |
| EP3852113A4 (fr) | Procédé, programme et appareil d'évaluation d'aptitude à la synthèse de composé | |
| SG11202012687SA (en) | Method for detection and quantification of genetic alterations | |
| EP3810807A4 (fr) | Méthodes et compositions pour l'analyse de biomarqueurs du cancer | |
| EP3679160A4 (fr) | Procédé d'utilisation de biomarqueurs et de variables cliniques pour prédire l'intérêt d'une chimiothérapie | |
| EP4087585A4 (fr) | Compositions et procédés de prévention de la récurrence de cancer | |
| GB201918692D0 (en) | Treatment and prognosis of pancreatic cancer | |
| EP3985380A4 (fr) | Procédé d'évaluation d'une fracture retardée d'un matériau métallique |